Locations:
Search
Findings from the prospective analysis and implications for diagnosing, preventing lethal prostate cancer
Large validation study corroborates previous findings, sets the stage for clinical use
How inhibiting the H6PD protein may reverse drug resistance
An effective, patient-centered biospy alternative
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
How these findings remove some clinical subjectivity, guide management
The metrics that matter, and how to become a top center for urology referrals
Cleveland Clinic researchers explore enterprise-wide testing registry to investigate
Study examines the relationship between outcomes and delay
New study examines rates of downgrading in patients with aggressive prostate cancer
This cell surface protein could be an immune checkpoint inhibition target
Advertisement
Advertisement